Abstract
IL-7 is critical for normal murine B cell development, however its role in human B lymphopoiesis is controversial. Here we examine the role of IL-7 in human B cell development using a novel in vitro model based on co-culturing cord blood (CB) and adult bone marrow (BM) hematopoietic stem cells (HSCs) on primary stroma from adult human BM. Addition of IL-7 to this co-culture model increased B cell production by ∼40-fold. IL-7-induced increases were dose-dependent and specific to CD19+ cells. Flow cytometry analysis of STAT5 phosphorylation, and expression of the IL-7Rα and the proliferation antigen, ki-67, indicate that IL-7 acts directly on B cell precursors and that this effect is at least partially mediated through increased proliferation. Ongoing studies are assessing the effects of IL-7 on apoptosis among B cell precursors. IL-7 effects appeared to be most profound in cultures initiated with adult human BM HSCs where few, if any, human B lineage cells are generated in the absence of either mouse or human IL-7 activity. However, when co-cultures initiated with CB and BM HSCs were compared, IL-7-induced increases were similar in magnitude, and B cell precursors responded similarly to IL-7. Therefore we compared CB and BM HSCs with respect to B lymphoid generative capacity. The ability of CB and BM HSCs to generate CD19- progeny in our cultures was not significantly different, however the in vitro B lymphoid generative capacity of adult BM HSCs was 40 times less than that of CB HSCs. Our results provide evidence that IL-7 is critical for B cell production from HSCs in adult BM due to their low B lymphoid generative capacity as compared to HSCs in CB. These studies have implications for B cell recovery following transplantation with stem cells from CB versus BM and suggest that B cell recovery could be impacted by availability of IL-7.
Author notes
Disclosure:Employment: Jaqueline Rogerio is now employed by Bayer Healthcare Pharmaceuticals. She had no connection to Bayer Healthcare Pharmaceuticals at the time that she contributed to this work. Membership Information: Kimberly Payne is a member of the scientific advisory board for Bioflow Technology, Inc. No data presented here was derived using products from that company.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal